theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Solid organ malignancy   

Questions discussed in this category


What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
Specifically, asymptomatic subsegmental PE diagnosed within a month from planned bilateral mastectomy for breast cancer. 
1 Answer available

Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?
1 Answer available

Does discovery of clonal hematopoiesis on liquid biopsy for solid tumors change your treatment approach in terms of which chemotherapy to offer for the solid tumor?
1 Answer available

How do you approach treatment of metastatic hepatocellular carcinoma in an adolescent?
Would you offer liver transplant in the setting of metastatic disease? 
1 Answer available

Would you continue TNFi for inflammatory arthritis if the patient develops a solid organ malignancy while on that therapy?
1 Answer available

What is the safest approach to treating refractory RA in the setting of an active solid organ malignancy?
Prior therapies include MTX, abatacept, rituximab
1 Answer available
171659794110961040580408138


Papers discussed in this category


Am J Kidney Dis, 2019 Aug 05
The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach.

Related Topics

  • Hematology
  • Pediatric Hematology/Oncology
  • Benign Hematology
  • Medical Oncology
  • General Hepatology
  • Malignancy
  • Rheumatology
  • Rheumatoid Arthritis
  • Pediatric Hematology
  • Thrombosis

Copyright © 2025 theMednet
All Rights Reserved.